TMCnet News
www.Xtremepicks.Com: Xtremepicks Alerts November 23, 2009 : RXII, FFIV, PBIB and CPBY(M2 PressWIRE Via Acquire Media NewsEdge) Xtremepicks.com Alerts include RXi Pharmaceuticals Corporation (Nasdaq: RXII), F5 Networks, Inc. (NASDAQ: FFIV), Porter Bancorp, Inc. (NASDAQ: PBIB) and China Information Security Technology, Inc., (Nasdaq: CPBY) RXi Pharmaceuticals Corporation (Nasdaq: RXII) trading at $2.13 per share on trading volume of 15,004 shares. In a press release out on November 23, RXi Pharmaceuticals Wins 2009 RNAi Technology Innovation of the Year Award from Frost & Sullivan WORCESTER, Mass., Nov 23, 2009 -- RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA(TM), and advanced delivery approaches. The rxRNA(TM) compounds are designed specifically for therapeutic use and contain many of the properties needed to develop RNAi-based drugs. About RXi Pharmaceuticals Corporation RXi Pharmaceuticals is a discovery-stage biopharmaceutical company pursuing the development and potential commercialization of proprietary therapeutics based on RNA interference (RNAi) for the treatment of human diseases. RXi has a comprehensive therapeutic platform that includes both RNAi compounds and potential delivery methods. RXi uses its own version of RNAi compounds -- rxRNA(TM) -- designed specifically for therapeutic use and contain many of the properties needed to move RNAi-based drugs into the clinic. RXi Pharmaceuticals believes it is well positioned to compete successfully in the RNAi-based therapeutics market with its accomplished scientific advisors, including Dr. Craig Mello, recipient of the 2006 Nobel Prize for his co-discovery of RNAi; a management team that is experienced in developing RNAi products; and a strong early intellectual property position in RNAi chemistry and delivery. www.rxipharma.com F5 Networks, Inc. (NASDAQ: FFIV) trading at $47.99 per share on trading volume of 375,751 shares. In a press release out on November 23, F5 Solutions Optimize Microsoft Windows 7 and Windows Server 2008 R2 Deployments New F5 Application Ready Solutions Offer High Performance, Availability, and Scalability for Microsoft Windows 7 and Windows Server 2008 R2 to Support an Increasingly Mobile Workforce SEATTLE, Nov 23, 2009 -- F5 Networks, Inc. (NASDAQ: FFIV), the global leader in Application Delivery Networking (ADN), today announced the release of new Application Ready Solutions for Microsoft Windows 7 and Windows Server 2008 R2. These F5(R) solutions provide support for Microsoft's recently released DirectAccess and BranchCache technologies, which are new features of the Windows(R) 7 and Windows Server(R) 2008 R2 operating systems. About F5 Networks F5 Networks is the global leader in Application Delivery Networking (ADN), focused on ensuring the secure, reliable, and fast delivery of applications. F5's flexible architectural framework enables community-driven innovation that helps organizations enhance IT agility and dynamically deliver services that generate true business value. F5's vision of unified application and data delivery offers customers an unprecedented level of choice in how they deploy ADN solutions. It redefines the management of application, server, storage, and network resources, streamlining application delivery and reducing costs. Global enterprise organizations, service and cloud providers, and Web 2.0 content providers trust F5 to keep their business moving forward. For more information, go to www.f5.com. Porter Bancorp, Inc. (NASDAQ: PBIB) trading at $15.09 on a volume of 778 shares In a press release out on November 23, Porter Bancorp, Inc. Declares Cash Dividend LOUISVILLE, Ky., Nov 23, 2009 -- Porter Bancorp, Inc. (NASDAQ: PBIB), parent company of PBI Bank, announced today that its Board of Directors declared a cash dividend of $0.20 per share. The dividend is payable on January 4, 2010, to shareholders of record as of December 15, 2009. The per share cash dividend represents the same amount as paid in the previous quarter taking into account the 5% stock dividend paid on November 19, 2009. About Porter Bancorp, Inc. Porter Bancorp, Inc., a bank holding company headquartered in Louisville, Kentucky, had $1.7 billion in assets as of September 30, 2009. Through Porter's subsidiary PBI Bank, it operates 18 full service banking offices in 12 counties in Kentucky. Porter Bancorp's common stock is traded on the Nasdaq Global Market under the symbol "PBIB." China Information Security Technology, Inc., (Nasdaq: CPBY) trading at $6.64 on a volume of 237,155 shares In a press release out on November 23, China Information Security Technology Ranked Among Deloitte Technology Fast 50 China SHENZHEN, China, Nov 23, 2009 -- China Information Security Technology, Inc., (Nasdaq: CPBY) ("China Information Security," "CIST" or the "Company"), a leading total solutions provider of digital security, geographic information, and hospital information systems in China, today announced that the Company has been ranked by Deloitte among the Technology Fast 50 China 2009 program for the second consecutive year. For 2009, CIST was ranked as the 15th fastest growing company, as compared to 25th in 2008. About China Information Security Technology, Inc. Through its wholly-owned Chinese subsidiary, China Information Security Technology, Inc. ("CIST" or the "Company") headquartered in Shenzhen, China ("PRC"), is a leading application software developer, systems integrator and full-service Geographic Information Systems ("GIS") solutions provider to the public security and civil-use markets in China, dedicated to the use of information technology to improve public safety and information management. Its main business lines range from digital information security, to GIS, and digital hospital information systems. The Company provides a broad portfolio of fully integrated solutions and services, including its First Responder Coordination Platform, Intelligent Border Control System, Residence Card Information Management System, Police- and Civil-use GIS products, and Digital Hospital Information System, to serve the growing demand for digital geographic information, hospital and electronic medical record systems in China. Its commitment to leading-edge technology and quality assurance has won the Company numerous government and enterprise contracts throughout China. To learn more about the Company, please visit its corporate website at http://www.chinacpby.com . Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience. Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at [email protected] Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm ((Comments on this story may be sent to [email protected])) (c) 2009 M2 COMMUNICATIONS |